These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 32271355)

  • 41. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.
    Chang VS; Dhaliwal DK; Raju L; Kowalski RP
    Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007].
    Yamaguchi K; Ohno A; Ishii Y; Tateda K; Iwata M; Kanda M; Akizawa K; Shimizu C; Kon S; Nakamura K; Matsuda K; Tominaga M; Nakagawa T; Sugita A; Ito T; Kato J; Suwabe A; Yamahata K; Kawamura C; Tashiro H; Horiuchi H; Katayama Y; Kondou S; Misawa S; Murata M; Kobayashi Y; Okamoto H; Yamazaki K; Okada M; Haruki K; Kanno H; Aihara M; Maesaki S; Hashikita G; Miyajima E; Sumitomo M; Saito T; Yamane N; Kawashima C; Akiyama T; Ieiri T; Yamamoto Y; Okamoto Y; Okabe H; Moro K; Shigeta M; Yoshida H; Yamashita M; Hida Y; Takubo T; Kusakabe T; Masaki H; Heijyou H; Nakaya H; Kawahara K; Sano R; Matsuo S; Kono H; Yuzuki Y; Ikeda N; Idomuki M; Soma M; Yamamoto G; Kinoshita S; Kawano S; Oka M; Kusano N; Kang D; Ono J; Yasujima M; Miki M; Hayashi M; Okubo S; Toyoshima S; Kaku M; Sekine I; Shiotani J; Horiuchi H; Tazawa Y; Yoneyama A; Kumasaka K; Koike K; Taniguchi N; Ozaki Y; Uchida T; Murakami M; Inuzuka K; Gonda H; Yamaguchi I; fujimoto Y; Iriyama J; Asano Y; Genma H; Maekawa M; Yoshimura H; Nakatani K; Baba H; Ichiyama S; Fujita S; Kuwabara M; Okazaki T; Fujiwara H; Ota H; Nagai A; Fujita J; Negayama K; Sugiura T; Kamioka M; Murase M; Yamane N; Nakasone I; Okayama A; Aoki Y; Kusaba K; Nakashima Y; Miyanohara H; Hiramatsu K; Saikawa T; Yanagihara K; Matsuda J; Kohno S; Mashiba K
    Jpn J Antibiot; 2009 Aug; 62(4):346-70. PubMed ID: 19860322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Infectious Keratitis Isolates and Susceptibility in Southern California.
    Gupta K; Unhale R; Garner OB; Deng SX; M Fung SS
    Cornea; 2022 Sep; 41(9):1094-1102. PubMed ID: 35315617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Shifting trends in bacterial keratitis in Toronto: an 11-year review.
    Lichtinger A; Yeung SN; Kim P; Amiran MD; Iovieno A; Elbaz U; Ku JY; Wolff R; Rootman DS; Slomovic AR
    Ophthalmology; 2012 Sep; 119(9):1785-90. PubMed ID: 22627118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus in ocular infections.
    Vola ME; Moriyama AS; Lisboa R; Vola MM; Hirai FE; Bispo PJ; Höfling-Lima AL
    Arq Bras Oftalmol; 2013; 76(6):350-3. PubMed ID: 24510081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998.
    Santos Sanches I; Mato R; de Lencastre H; Tomasz A;
    Microb Drug Resist; 2000; 6(3):199-211. PubMed ID: 11144420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)].
    Shimada K; Nakano K; Ohno I; Okada S; Hayashi K; Yokouchi H; Arakawa M; Gejyo F; Igarashi K; Ikemoto H; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Inagawa H; Ando M; Suga M; Sato K; Kudo K; Kobayashi N; Tosaka M; Hasegawa M; Kohno S; Tomono K; Miyazaki Y; Kobayashi H; Kawai S; Takayasu S; Hirakata Y; Matsuda J; Mochida C; Ito A; Sumitomo M; Nasu M; Nagai H; Matsushima T; Niki Y; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2001 Jul; 54(7):331-64. PubMed ID: 11560054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa.
    Shittu AO; Lin J
    BMC Infect Dis; 2006 Jul; 6():125. PubMed ID: 16875502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002.
    Morrissey I; Burnett R; Viljoen L; Robbins M
    J Infect; 2004 Aug; 49(2):109-14. PubMed ID: 15236917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)].
    Ikemoto H; Arakawa M; Gejyo F; Igarashi K; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Sekine O; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Ohno I; Okada S; Inagawa H; Kudo K; Kobayashi N; Ando M; Suga M; Sato K; Kondo T; Tosaka M; Kobayashi H; Kawai S; Takayasu S; Kohno S; Tomono K; Shimada K; Nakano K; Miyazaki Y; Izumikawa K; Yamaguchi T; Mochida C; Yokouchi H; Ito A; Sumitomo M; Nasu M; Nagai H; Yamasaki T; Matsushima T; Nakano T
    Jpn J Antibiot; 2000 May; 53(5):261-98. PubMed ID: 10923284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
    Kowalski RP; Kowalski TA; Shanks RM; Romanowski EG; Karenchak LM; Mah FS
    Cornea; 2013 Jun; 32(6):830-4. PubMed ID: 23132444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals.
    Rogues AM; Dumartin C; Amadéo B; Venier AG; Marty N; Parneix P; Gachie JP
    Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1389-95. PubMed ID: 17994520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
    Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures.
    Fintelmann RE; Hoskins EN; Lietman TM; Keenan JD; Gaynor BD; Cevallos V; Acharya NR
    Arch Ophthalmol; 2011 Apr; 129(4):399-402. PubMed ID: 21482865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.